JP2013516469A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013516469A5 JP2013516469A5 JP2012548078A JP2012548078A JP2013516469A5 JP 2013516469 A5 JP2013516469 A5 JP 2013516469A5 JP 2012548078 A JP2012548078 A JP 2012548078A JP 2012548078 A JP2012548078 A JP 2012548078A JP 2013516469 A5 JP2013516469 A5 JP 2013516469A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- human
- antigen
- immune response
- stimulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 14
- 239000000427 antigen Substances 0.000 claims 7
- 102000036639 antigens Human genes 0.000 claims 7
- 108091007433 antigens Proteins 0.000 claims 7
- 230000028993 immune response Effects 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 230000004936 stimulating effect Effects 0.000 claims 4
- 108010040721 Flagellin Proteins 0.000 claims 3
- 108020001507 fusion proteins Proteins 0.000 claims 3
- 102000037865 fusion proteins Human genes 0.000 claims 3
- 206010022000 influenza Diseases 0.000 claims 3
- 239000002245 particle Substances 0.000 claims 3
- 101710154606 Hemagglutinin Proteins 0.000 claims 1
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 1
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 1
- 101710176177 Protein A56 Proteins 0.000 claims 1
- 230000005875 antibody response Effects 0.000 claims 1
- 239000000185 hemagglutinin Substances 0.000 claims 1
- 239000002502 liposome Substances 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 claims 1
- 239000004005 microsphere Substances 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 230000003472 neutralizing effect Effects 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 238000002255 vaccination Methods 0.000 claims 1
- 239000000277 virosome Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29259310P | 2010-01-06 | 2010-01-06 | |
| US61/292,593 | 2010-01-06 | ||
| PCT/US2011/020159 WO2011084967A2 (en) | 2010-01-06 | 2011-01-05 | Methods and compositions for providing protective immunity in the elderly |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013516469A JP2013516469A (ja) | 2013-05-13 |
| JP2013516469A5 true JP2013516469A5 (enExample) | 2014-02-20 |
Family
ID=44306116
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012548078A Pending JP2013516469A (ja) | 2010-01-06 | 2011-01-05 | 高齢者に保護免疫を提供するための方法及び組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20130095130A1 (enExample) |
| EP (1) | EP2521563B1 (enExample) |
| JP (1) | JP2013516469A (enExample) |
| KR (1) | KR20120129893A (enExample) |
| CN (1) | CN102740872A (enExample) |
| AU (1) | AU2011203740B2 (enExample) |
| CA (1) | CA2786306A1 (enExample) |
| MX (1) | MX2012007916A (enExample) |
| SG (1) | SG182305A1 (enExample) |
| WO (1) | WO2011084967A2 (enExample) |
| ZA (1) | ZA201205273B (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008527009A (ja) | 2005-01-19 | 2008-07-24 | バクシネート コーポレーション | 病原体関連分子パターンおよび抗原を含む組成物ならびに免疫応答を刺激するためのそれらの使用 |
| EP2476432B1 (en) | 2006-03-07 | 2015-08-19 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
| SG190562A1 (en) | 2008-04-18 | 2013-06-28 | Vaxinnate Corp | Deletion mutants of flagellin and methods of use |
| US8932598B2 (en) * | 2012-08-28 | 2015-01-13 | Vaxinnate Corporation | Fusion proteins and methods of use |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5976552A (en) * | 1995-04-28 | 1999-11-02 | Protein Sciences Corporation | Virus vaccines |
| US20030232055A1 (en) * | 2000-07-31 | 2003-12-18 | Ruslan Medzhitov | Innate immune system-directed vaccines |
| US20050013812A1 (en) * | 2003-07-14 | 2005-01-20 | Dow Steven W. | Vaccines using pattern recognition receptor-ligand:lipid complexes |
| EP1827489B1 (en) * | 2004-12-16 | 2012-10-31 | Wake Forest University Health Sciences | Use of flagellin in tumor immunotherapy |
| JP2008524261A (ja) * | 2004-12-21 | 2008-07-10 | バクシネート コーポレーション | インフルエンザウイルスタンパク質の組成物およびその使用方法 |
| US20090162400A1 (en) * | 2004-12-21 | 2009-06-25 | Powell Thomas J | Compositions of influenza viral proteins and methods of use thereof |
| CA2596079A1 (en) * | 2005-01-31 | 2006-08-10 | Vaxinnate Corporation | Novel polypeptide ligands for toll-like receptor 2 (tlr2) |
| EP1863529A1 (en) * | 2005-03-23 | 2007-12-12 | GlaxoSmithKline Biologicals S.A. | Novel composition |
| EP2476432B1 (en) * | 2006-03-07 | 2015-08-19 | Vaxinnate Corporation | Compositions that include hemagglutinin, methods of making and methods of use thereof |
| SG190562A1 (en) * | 2008-04-18 | 2013-06-28 | Vaxinnate Corp | Deletion mutants of flagellin and methods of use |
| WO2009130618A2 (en) * | 2008-04-25 | 2009-10-29 | Institute For Systems Biology | Flagellin polypeptide vaccines |
-
2011
- 2011-01-05 MX MX2012007916A patent/MX2012007916A/es not_active Application Discontinuation
- 2011-01-05 WO PCT/US2011/020159 patent/WO2011084967A2/en not_active Ceased
- 2011-01-05 JP JP2012548078A patent/JP2013516469A/ja active Pending
- 2011-01-05 CN CN2011800069618A patent/CN102740872A/zh active Pending
- 2011-01-05 KR KR1020127019714A patent/KR20120129893A/ko not_active Ceased
- 2011-01-05 EP EP11732058.0A patent/EP2521563B1/en not_active Not-in-force
- 2011-01-05 AU AU2011203740A patent/AU2011203740B2/en not_active Ceased
- 2011-01-05 US US13/519,912 patent/US20130095130A1/en not_active Abandoned
- 2011-01-05 SG SG2012048617A patent/SG182305A1/en unknown
- 2011-01-05 CA CA2786306A patent/CA2786306A1/en not_active Abandoned
-
2012
- 2012-07-16 ZA ZA2012/05273A patent/ZA201205273B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7523897B2 (ja) | 呼吸器合胞体ウイルス（ｒｓｖ）ワクチン | |
| Al-Halifa et al. | Nanoparticle-based vaccines against respiratory viruses | |
| Sulczewski et al. | Nanoparticle vaccines against viral infections | |
| Zaman et al. | Strategies for intranasal delivery of vaccines | |
| Tao et al. | M2e-immobilized gold nanoparticles as influenza A vaccine: Role of soluble M2e and longevity of protection | |
| HRP20171213T1 (hr) | Glikoproteinske čestice nalik virusu (vlp) bjesnoće | |
| JP2011250797A5 (enExample) | ||
| JP2017538672A5 (enExample) | ||
| JP2013530158A5 (enExample) | ||
| JP2013518052A5 (enExample) | ||
| Watkins et al. | A single dose and long lasting vaccine against pandemic influenza through the controlled release of a heterospecies tandem M2 sequence embedded within detoxified bacterial outer membrane vesicles | |
| RU2017137357A (ru) | Быстрорастворяющаяся лекарственная форма пероральной вакцины, в которой используют крахмал | |
| US10874737B2 (en) | Influenza nanovaccine | |
| Hashemzadeh et al. | Vaccines based on virus-like nano-particles for use against Middle East Respiratory Syndrome (MERS) coronavirus | |
| Cossette et al. | Intranasal subunit vaccination strategies employing nanomaterials and biomaterials | |
| JP2010506926A5 (enExample) | ||
| JP2012102105A5 (enExample) | ||
| JP2020504179A (ja) | 汎用インフルエンザワクチン組成物 | |
| JP2013516469A5 (enExample) | ||
| Stephens et al. | Nanoparticle vaccines against respiratory syncytial virus | |
| Zhao et al. | Adjuvant-free, self− assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses | |
| Nesovic et al. | Delivery of gold nanoparticle-conjugated M2e influenza vaccine in mice using coated microneedles | |
| Zhang et al. | Cationic nanoparticle-stabilized vaccine delivery system for the H9N2 vaccine to promote immune response in chickens | |
| Nie et al. | Self-adjuvant multiepitope nanovaccine based on ferritin induced long-lasting and effective mucosal immunity against H3N2 and H1N1 viruses in mice | |
| JP2015525794A5 (enExample) |